Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5506 to 5520 of 7681 results

  1. Impact of neonatal infection on the baby's family: What is the impact of neonatal infection on the health-related quality of life of the baby's family?

    Recommendation ID NG195/7 Question Impact of neonatal infection on the baby's family: What is the impact of neonatal infection on the health-related

    Research recommendation
    Published
    6 August 2021

  2. What is the impact of pharmacological interventions for the management of postpartum haemorrhage on breastfeeding and women's and their birth companions' experience and satisfaction in the postnatal period?

    Recommendation ID NG235/4 Question What is the impact of pharmacological interventions for the management of postpartum haemorrhage on

    Research recommendation
    Published
    11 January 2024

  3. Intracranial hypertension: What is the impact of routine monitoring of intracranial hypertension on subsequent management and outcome in people with aneurysmal subarachnoid haemorrhage who are unconscious or ventilated on an intensive care unit?

    Recommendation ID NG228/09 Question Intracranial hypertension: What is the impact of routine monitoring of intracranial hypertension on

    Research recommendation
    Published
    12 December 2022

  4. What is the impact of using the VivaScope 1500 and 3000 imaging systems in the clinical workflow of melanoma and basal cell carcinoma assessment in secondary care in England, particularly on excision rates, diagnostic accuracy, health related quality of life and associated NHS costs?

    Recommendation ID DG19/1 Question What is the impact of using the VivaScope 1500 and 3000 imaging systems in the clinical workflow of melanoma

    Research recommendation
    Published
    12 January 2016

  5. What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can be obtained when using a complete individual patient-based outcomes meta-analysis data set compared with using published outcomes data?

    Recommendation ID CG181/2 Question What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can

    Research recommendation
    Published
    9 June 2015

  6. What is the incidence and prevalence of, and what are the demographic trends in, skin cancer in the UK? (Demographic variables might include whether someone is an outdoor or indoor worker, their skin type and socioeconomic status.)

    Recommendation ID PH32/1 Question What is the incidence and prevalence of, and what are the demographic trends in, skin cancer in the UK

    Research recommendation
    Published
    9 June 2015

  7. Antibiotics for suspected early-onset infection: What is the incidence and severity of adverse effects with antibiotics used to prevent or treat early-onset neonatal infection?

    Recommendation ID NG195/13 Question Antibiotics for suspected early-onset infection: What is the incidence and severity of adverse effects

    Research recommendation
    Published
    6 August 2021

  8. What are the most effective and cost-effective interventions to help older employees stay in or re-enter work? For example, to overcome the problems of a change in job specification?

    Recommendation ID NG13/6 Question What are the most effective and cost-effective interventions to help older employees stay in or re-enter

    Research recommendation
    Published
    17 November 2016

  9. What are the most effective and cost-effective interventions to maintain and improve the health and wellbeing of older employees?

    Recommendation ID NG13/5 Question What are the most effective and cost-effective interventions to maintain and improve the health and wellbeing

    Research recommendation
    Published
    17 November 2016

  10. Use of image- and performance-enhancing drugs:- What are the most effective and cost effective interventions to prevent and reduce the use of image- and performance-enhancing drugs?

    Recommendation ID NG64/6 Question Use of image- and performance-enhancing drugs:- What are the most effective and cost effective interventions

    Research recommendation
    Published
    4 May 2017

  11. What are the most effective and cost-effective mid-life services and interventions in the long term for reducing behavioural risk, leading to healthier ageing and preventing or delaying the development of dementia, disability and frailty in later life? How can these be delivered in a consistent and sustainable manner? How can multiple interventions be effectively packaged to maximise efficiency? What are the barriers and facilitators to the uptake of services and interventions, and to the development and maintenance of healthy behaviours of people in mid-life? What are the effects on health inequalities?

    Recommendation ID NG16/3 Question What are the most effective and cost-effective mid-life services and interventions in the long term for

    Research recommendation
    Published
    9 December 2015

  12. What are the most effective and cost-effective population-level measures to help people in mid-life maintain or adopt healthy behaviours and build up resilience to dementia, disability and frailty? What are the best methods for evaluating their effect? How do these measures affect health inequalities?

    Recommendation ID NG16/2 Question What are the most effective and cost-effective population-level measures to help people in mid-life maintain

    Research recommendation
    Published
    9 December 2015

  13. What are the most effective and cost effective ways of delivering needle and syringe programmes to: young people aged under 18; users of image- and performance- enhancing drugs?

    Recommendation ID PH52/2 Question What are the most effective and cost effective ways of delivering needle and syringe programmes to: young

    Research recommendation
    Published
    9 June 2015

  14. What are the most effective and cost effective ways of developing, implementing and assessing tailored and culturally appropriate community-level interventions to prevent type 2 diabetes among people at high risk? This includes people from a range of black and minority ethnic groups and those from lower socioeconomic communities.

    Recommendation ID PH35/2 Question What are the most effective and cost effective ways of developing, implementing and assessing tailored

    Research recommendation
    Published
    9 June 2015

  15. Underserved groups:- What are the most effective and cost-effective ways of reaching underserved groups and removing barriers to access in order to increase their uptake of flu vaccination?

    Recommendation ID NG103/2 Question Underserved groups:- What are the most effective and cost-effective ways of reaching underserved groups

    Research recommendation
    Published
    12 December 2018